While it is complicated to identify the modifying gene/s that interact with apoA-IV in these two different background mice, a thorough understanding of the modifying genes using advanced technology, e.g., RNA sequence, will be invaluable to human biology and the opportunity to develop drugs for human obesity and diabetes. This evidence concerns the gene APOA4 and obesity due to melanocortin 4 receptor deficiency.